Back to Search
MI NA SON, M.D
M.D
Internal Medicine Physician
NPI: 1801067707IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
D00666963(MD)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
OTHER
Class of 2002
Research & Publications (20)
Engineering of FRT-lacZ fusion constructs: induction of the Pseudomonas aeruginosa fadAB1 operon by medium and long chain-length fatty acids.
PMID 18221997·Plasmid·2008
8-other
Rapamycin promotes the osteoblastic differentiation of human embryonic stem cells by blocking the mTOR pathway and stimulating the BMP/Smad pathway.
PMID 19642865·Stem Cells Dev·2010
8-other
Notch signaling is required for maintaining stem-cell features of neuroprogenitor cells derived from human embryonic stem cells.
PMID 19682396·BMC Neurosci·2009
8-other
Treatment of Kawasaki disease: analysis of 27 US pediatric hospitals from 2001 to 2006.
PMID 19564276·Pediatrics·2009
4-observational
The effect of variable yield strength and variable fractal dimension on flocculation of cohesive sediment.
PMID 19559457·Water Res·2009
8-other
Deaths from pesticide poisoning in South Korea: trends over 10 years.
PMID 18600341·Int Arch Occup Environ Health·2009
8-other
Elevation of intracellular cyclic AMP inhibits NF-kappaB-mediated thymosin beta4 expression in melanoma cells.
PMID 19500569·Exp Cell Res·2009
7-preclinical
SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma.
PMID 19427293·Cell Stem Cell·2009
7-preclinical
Production of flavonoid o-glucoside using sucrose synthase and flavonoid o-glucosyltransferase fusion protein.
PMID 19652519·J Microbiol Biotechnol·2009
8-other
Proteomic analysis of fungal host factors differentially expressed by Fusarium graminearum infected with Fusarium graminearum virus-DK21.
PMID 19374926·Virus Res·2009
4-observational
Development of a sustained-release recombinant human growth hormone formulation.
PMID 19332090·J Control Release·2009
7-preclinical
Induction of pacemaker currents by DA-9701, a prokinetic agent, in interstitial cells of Cajal from murine small intestine.
PMID 19326077·Mol Cells·2009
7-preclinical
Redox susceptibility of SOD1 mutants is associated with the differential response to CCS over-expression in vivo.
PMID 19320055·Neurobiol Dis·2009
7-preclinical
Genetic polymorphisms of hypoxia-inducible factor-1 alpha and cardiovascular disease in hemodialysis patients.
PMID 19602906·Nephron Clin Pract·2009
8-other
PAR-1622 is a selective peroxisome proliferator-activated receptor gamma partial activator with preserved antidiabetic efficacy and broader safety profile for fluid retention.
PMID 19471887·Arch Pharm Res·2009
4-observational
Assessing the risks of aquatic species invasions via European inland waterways: from concepts to environmental indicators.
PMID 19431296·Integr Environ Assess Manag·2009
7-preclinical
Design, synthesis, and evaluation of novel aryl-tetrahydropyridine PPARalpha/gamma dual agonists.
PMID 18771917·Bioorg Med Chem Lett·2008
7-preclinical
PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.
PMID 18727927·Eur J Pharmacol·2008
7-preclinical
Long exposure of non-cytotoxic concentrations of methylselenol suppresses the invasive potential of B16F10 melanoma.
PMID 18695906·Oncol Rep·2008
7-preclinical
Shikonins attenuate microglial inflammatory responses by inhibition of ERK, Akt, and NF-kappaB: neuroprotective implications.
PMID 18657551·Neuropharmacology·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4500 PARSONS BLVD
FLUSHING, NY 11355 - Phone
- (718) 670-3000
Quick Facts
- NPI
- 1801067707
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 24
- Publications
- 20
Are you this provider?
Claim Your Profile